It is a pharma private limited company based in Fatuha, Bihar, India, established in 1985.
1985 | Fatuha, Bihar, India | ActiveKras Pharmaceuticals Private Limited, a active private limited company, was established on 27 September 1985 in Fatuha, Bihar, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U00304BR1985PTC002219. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
It upholds a compliant status. Its leadership includes Ravi Shankar (Director), Vinita Bhushan (Director), Rupesh Kumar (Director). Past directors included Sushil Kumar Jaiswal, Sudhir Kumar Jaiswal, Ashok Kumar Jaiswal. It holds ₹3.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Kras Pharmaceuticals Private Ltd, C-15 2Nd Phase, Industrial Area, Fatuha, Bihar, 803201.
U00304BR1985PTC002219
002219
27 September 1985
₹1.50 Cr
₹1.50 Cr
Roc Patna
Unlisted
Active
Explore comprehensive insights into Kras Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Shankar | Director | 02 Jan 2019 | Current |
| Vinita Bhushan | Director | 01 Sep 2020 | Current |
| Rupesh Kumar | Director | 01 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
| Pramod Abcsdd | Director | 01 Jul 2016 | Past |
| Pramod Abcsdd | Director | 11 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kras Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.47% increase. The company also saw a substantial improvement in profitability, with a 34.41% increase in profit. The company's net worth moved up by a moderate rise of 2.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Kras Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,248,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2023 | Hdfc Bank Limited | ₹5.87 M | Open |
| 09 Sep 2022 | Hdfc Bank Limited | ₹2.40 Cr | Open |
| 29 Dec 2021 | Indian Bank | ₹2.38 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kras Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kras Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kras Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kras Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 2.40 Cr registered on 09 Sep 2022 with Charge ID 100676472 was modified on 08 Aug 2024. was documented.
Progress on Kras Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.59 Cr with Charge ID 100922316 was registered on 30 Dec 2023. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.40 Cr with Charge ID 100676472 was registered on 09 Sep 2022. was documented.
The activity A charge with Indian Bank amounted to Rs. 0.24 Cr with Charge ID 100560160 was registered on 29 Dec 2021. was completed.
The CIN of Kras Pharmaceuticals Private Limited is U00304BR1985PTC002219.
Kras Pharmaceuticals Private Limited is headquartered at C/O Kras Pharmaceuticals Private Ltd, C-15 2Nd Phase, Industrial Area, Fatuha, Bihar, 803201.
Kras Pharmaceuticals Private Limited was incorporated on 27 September 1985.
The current directors of Kras Pharmaceuticals Private Limited are
The primary industry of Kras Pharmaceuticals Private Limited is Trade.
Kras Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kras Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Kras Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX